ES2107279T3 - Diesteres de fosfato para el tratamiento de enfermedades proliferativas de la epidermis. - Google Patents

Diesteres de fosfato para el tratamiento de enfermedades proliferativas de la epidermis.

Info

Publication number
ES2107279T3
ES2107279T3 ES95302497T ES95302497T ES2107279T3 ES 2107279 T3 ES2107279 T3 ES 2107279T3 ES 95302497 T ES95302497 T ES 95302497T ES 95302497 T ES95302497 T ES 95302497T ES 2107279 T3 ES2107279 T3 ES 2107279T3
Authority
ES
Spain
Prior art keywords
epidermis
proliferative diseases
diesters
phosphate
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95302497T
Other languages
English (en)
Inventor
Kazumi Ogata
Rie Nagao
Takahiro Sakaue
Shinya Ogino
Sachiko Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2107279T3 publication Critical patent/ES2107279T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LAS ENFERMEDADES PROLIFERATIVAS DE LA EPIDERMIS SE TRATAN CON COMPUESTO DE DIESTER FOSFORICO CON LA SIGUIENTE FORMULA I O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LA MISMA. [EN DONDE R{SUB,1} Y R{SUB,2} SON IGUALES O DIFERENTES Y CADA UNA REPRESENTA HIDROGENO O METILO].
ES95302497T 1994-04-22 1995-04-13 Diesteres de fosfato para el tratamiento de enfermedades proliferativas de la epidermis. Expired - Lifetime ES2107279T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8424894 1994-04-22

Publications (1)

Publication Number Publication Date
ES2107279T3 true ES2107279T3 (es) 1997-11-16

Family

ID=13825166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95302497T Expired - Lifetime ES2107279T3 (es) 1994-04-22 1995-04-13 Diesteres de fosfato para el tratamiento de enfermedades proliferativas de la epidermis.

Country Status (6)

Country Link
EP (1) EP0679399B1 (es)
KR (1) KR950031085A (es)
AT (1) ATE156359T1 (es)
DE (1) DE69500511T2 (es)
ES (1) ES2107279T3 (es)
TW (1) TW287103B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209690A1 (en) * 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU2002317053B2 (en) * 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
RU2434643C2 (ru) * 2005-06-17 2011-11-27 Вайтал Хэлф Сайнсис Пти Лтд Транспортирующий наполнитель, содержащий один или более ди и/или моно-(электронный передающий агент) фосфатных производных или их соединений
MX2007015949A (es) * 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
US5122536A (en) * 1989-10-12 1992-06-16 Perricone Nicholas V Method for the topical treatment of psoriasis

Also Published As

Publication number Publication date
EP0679399B1 (en) 1997-08-06
KR950031085A (ko) 1995-12-18
DE69500511T2 (de) 1998-01-02
ATE156359T1 (de) 1997-08-15
EP0679399A1 (en) 1995-11-02
TW287103B (es) 1996-10-01
DE69500511D1 (de) 1997-09-11

Similar Documents

Publication Publication Date Title
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
DE69500511D1 (de) Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis
AU689304B2 (en) Quinazoline derivative
ES2166381T3 (es) Tratamiento de enfermedades vasculares hiperproliferativas.
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
ATE227717T1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
MX9203945A (es) Esteres bisfosfonicos de pirazolpirimidina y pirimidinilo como antiinflamatorios
GR3033020T3 (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses.
ES2142413T3 (es) 1,2,4-triazolo(1,5-a)pirimidinas y su uso en el tratamiento de enfermedades neurologicas.
ES2124477T3 (es) Uso de un fosfato de ascorbilo y tocoferilo para la preparacion de un medicamento para el tratamiento de la pancreatitis.
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
NO990436D0 (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK0551844T3 (da) Svovlholdige galdesyrederivater
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
DK0682023T3 (da) Imidazopyridinderivater og fremgangsmåde til fremstilling deraf
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.
ES2159087T3 (es) Oxindoles sustituidos con adamantilo como agentes farmaceuticos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 679399

Country of ref document: ES